Skip to main content

Table 2 Newcastle–Ottawa assessment scale quality assessment

From: Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and systemic lupus erythematosus

Study ID

Selection

Comparability

Exposure

 

S1

S2

S3

S4

C1

C2

E1a

E1b

E2

E3

E4

Berkun and colleagues [19]

*

–

*

*

*

*

–

–

–

*

–

Chen and colleagues [20]

*

–

–

–

*

*

–

–

*

*

–

Chen and colleagues [21]

*

*

–

*

–

–

–

–

*

*

–

Esen and colleagues [37]

*

*

–

*

–

–

–

–

*

*

–

Evans [22]

*

–

–

*

–

*

**

n/a

*

*

–

Gergely and colleagues [23]

–

–

–

–

*

*

–

–

*

*

–

Huggins and colleagues [24]

*

–

–

*

–

–

–

–

–

*

–

James and colleagues [13]

*

–

–

–

*

*

–

–

*

*

–

James and colleagues [25]

*

–

–

*

*

*

–

–

*

*

–

Kitagawa and colleagues [26]

*

–

–

–

–

–

–

–

–

*

–

Lau and colleagues [27]

*

–

–

–

–

–

–

–

–

*

–

Lu and colleagues [28]

*

–

–

–

*

*

–

–

*

*

–

Marchini and colleagues [29]

–

–

–

–

–

–

–

–

–

*

–

Newkirk and colleagues [39]

*

–

–

*

–

–

–

–

*

*

–

Ngou and colleagues [30]

*

–

–

–

–

–

–

–

–

*

–

Parks and colleagues [18]

*

*

*

–

*

*

**

n/a

*

*

–

Stratta and colleagues [31]

*

–

–

*

–

*

–

*

–

*

–

Stevens and colleagues [32]

–

–

–

*

–

–

**

n/a

–

*

–

Sun and colleagues [15]

*

–

–

*

*

*

–

–

–

*

–

Tazi and colleagues [33]

*

*

–

*

*

*

–

–

*

*

*

Tsai and colleagues [34]

*

–

–

*

*

–

–

–

*

*

–

Us and colleagues [38]

*

–

–

*

–

–

–

–

–

*

–

Westgeest and colleagues [40]

*

–

–

*

–

–

–

–

–

*

–

Yokochi and colleagues [35]

*

–

–

*

–

–

–

–

–

*

–

Zhang and colleagues [36]

–

–

*

*

–

–

–

*

*

*

–

  1. S1, objective case definition used; S2, cases consecutively recruited or obviously representative; S3, community controls; S4, controls specified as having no history of disease; C1, controls matched for age; C2, controls matched for another factor; E1a, samples analysts blind to patient group (two stars); E1b, analysis conducted in clinical laboratory; E2, explicit laboratory cutoff value for positive result; E3, same method of ascertainment for cases and controls; E4, missing data reported. n/a, not available.